Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 671431, 13 pages
http://dx.doi.org/10.1155/2014/671431
Research Article

Flow Cytometric Detection of p38 MAPK Phosphorylation and Intracellular Cytokine Expression in Peripheral Blood Subpopulations from Patients with Autoimmune Rheumatic Diseases

1Department of Rheumatology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41110 Larissa, Greece
2Cellular Immunotherapy and Molecular Immunodiagnostics, Biomedical Section, Centre for Research & Technology Hellas (CE.R.T.H.)/Institute for Research and Technology-Thessaly (I.RE.TE.TH), 41222 Larissa, Greece
3Division of Transplantation Immunology and Mucosal Biology, Institute of Liver Studies, King’s College London School of Medicine King’s College Hospital, London SE5 9RS, UK
4Department of Dermatology, School of Health Sciences, Faculty of Medicine, University of Thessaly, Biopolis, 41110 Larissa, Greece
5Department of Internal Medicine, School of Health Sciences, Faculty of Medicine, University of Thessaly, Biopolis, 41110 Larissa, Greece

Received 11 September 2013; Accepted 13 November 2013; Published 3 February 2014

Academic Editor: Yehuda Shoenfeld

Copyright © 2014 Athanasios Mavropoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Vivier, J. A. Nunès, and F. Vély, “Natural killer cell signaling pathways,” Science, vol. 306, no. 5701, pp. 1517–1519, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Yu, M. Wei, B. Becknell et al., “Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells,” Immunity, vol. 24, no. 5, pp. 575–590, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Mavropoulos, G. Sully, A. P. Cope, and A. R. Clark, “Stabilization of IFN-γ mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells,” Blood, vol. 105, no. 1, pp. 282–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Thalhamer, M. A. McGrath, and M. M. Harnett, “MAPKs and their relevance to arthritis and inflammation,” Rheumatology, vol. 47, no. 4, pp. 409–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. I. Sakkas, I. C. Chikanza, and C. D. Platsoucas, “Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis,” Nature Clinical Practice Rheumatology, vol. 2, no. 12, pp. 679–685, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. I. Sakkas, “New developments in the pathogenesis of systemic sclerosis,” Autoimmunity, vol. 38, no. 2, pp. 113–116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. L. I. Sakkas, B. Xu, C. M. Artlett, S. Lu, S. A. Jimenez, and C. D. Platsoucas, “Oligoclonal T cell expansion in the skin of patients with systemic sclerosis,” Journal of Immunology, vol. 168, no. 7, pp. 3649–3659, 2002. View at Google Scholar · View at Scopus
  8. L. Šenolt, J. Vencovský, K. Pavelka, C. Ospelt, and S. Gay, “Prospective new biological therapies for rheumatoid arthritis,” Autoimmunity Reviews, vol. 9, no. 2, pp. 102–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Loza, J. S. Faust, and B. Perussia, “Multiple color immunofluorescence for cytokine detection at the single-cell level,” Applied Biochemistry and Biotechnology B, vol. 23, no. 3, pp. 245–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Rostaing, J. Tkaczuk, M. Durand et al., “Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells,” Cytometry, vol. 35, no. 4, pp. 318–328, 1999. View at Google Scholar
  11. P. O. Krutzik, J. M. Irish, G. P. Nolan, and O. D. Perez, “Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications,” Clinical Immunology, vol. 110, no. 3, pp. 206–221, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. O. D. Perez and G. P. Nolan, “Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry,” Nature Biotechnology, vol. 20, no. 2, pp. 155–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Wu, L. Jin, L. Vence, and L. G. Radvanyi, “Development and application of “phosphoflow” as a tool for immunomonitoring,” Expert Review of Vaccines, vol. 9, no. 6, pp. 631–643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. O. D. Perez and G. P. Nolan, “Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level,” Immunological Reviews, vol. 210, pp. 208–228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. K. R. Schulz, E. A. Danna, P. O. Krutzik, and G. P. Nolan, “Single-cell phospho-protein analysis by flow cytometry,” Current Protocols in Immunology, chapter 8, unit 8.17, 2007. View at Publisher · View at Google Scholar
  16. J. Saklatvala, “The p38 MAP kinase pathway as a therapeutic target in inflammatory disease,” Current Opinion in Pharmacology, vol. 4, no. 4, pp. 372–377, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Mavropoulos, T. Orfanidou, C. Liaskos et al., “p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris,” Autoimmunity Reviews, vol. 12, no. 5, pp. 580–590, 2012. View at Google Scholar
  18. G. L. Schieven, “The p38alpha kinase plays a central role in inflammation,” Current Topics in Medicinal Chemistry, vol. 9, no. 11, pp. 1038–1048, 2009. View at Google Scholar
  19. A. Mavropoulos, D. Smyk, E. I. Rigopoulou, and D. P. Bogdanos, “Human peripheral blood mononuclear cell culture for flow cytometric analysis of phosphorylated mitogen-activated protein kinases,” Methods in Molecular Biology, vol. 806, pp. 275–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Mavropoulos, E. Spyrou, E. I. Rigopoulou, D. Vergani, G. N. Dalekos, and D. P. Bogdanos, “1107 Phosphorylation of P38 MAPK is detectable in NKT cells of patients with autoimmune hepatitis in whom it mirrors disease activity,” Journal of Hepatology, vol. 52, p. S428, 2010. View at Google Scholar
  21. D. T. Montag and M. T. Lotze, “Rapid flow cytometric measurement of cytokine-induced phosphorylation pathways [CIPP] in human peripheral blood leukocytes,” Clinical Immunology, vol. 121, no. 2, pp. 215–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. N. E. Aerts, D. G. Ebo, C. H. Bridts, W. J. Stevens, and L. S. de Clerck, “Flow cytometric analysis of phospho-p38 mitogen-activated kinase (MAPK): p38 MAPK does not mediate the effect of adalimumab on peripheral T cell cytokine production in rheumatoid arthritis,” Cytokine, vol. 47, no. 3, pp. 178–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. T. Montag and M. T. Lotze, “Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cells,” Journal of Immunological Methods, vol. 313, no. 1-2, pp. 48–60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. P. O. Krutzik and G. P. Nolan, “Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events,” Cytometry A, vol. 55, no. 2, pp. 61–70, 2003. View at Google Scholar · View at Scopus
  25. H. Rabinowich, L. Pricop, R. B. Herberman, and T. L. Whiteside, “Expression and function of CD7 molecule on human natural killer cells,” Journal of Immunology, vol. 152, no. 2, pp. 517–526, 1994. View at Google Scholar · View at Scopus
  26. J. M. Milush, B. R. Long, J. E. Snyder-Cappione et al., “Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4,” Blood, vol. 114, no. 23, pp. 4823–4831, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Lima, M. dos Anjos Teixeira, M. L. Queirós et al., “Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties,” Blood Cells, Molecules, and Diseases, vol. 27, no. 4, pp. 731–743, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Lima, J. Almeida, M. dos Anjos Teixeira, M. L. Queirós, B. Justiça, and A. Orfão, “The “ex vivo” patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR expression identify acute/early and chronic/late NK-cell activation states,” Blood Cells, Molecules, and Diseases, vol. 28, no. 2, pp. 181–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Fahlén-Yrlid, T. Gustafsson, J. Westlund et al., “CD11chigh dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization,” Journal of Immunology, vol. 183, no. 8, pp. 5032–5041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Rovati, S. Mariucci, M. Manzoni, K. Bencardino, and M. Danova, “Flow cytometric detection of circulating dendritic cells in healthy subjects,” European Journal of Histochemistry, vol. 52, no. 1, pp. 45–51, 2008. View at Google Scholar · View at Scopus
  31. A. M. Frias, C. D. Porada, K. B. Crapnell, J. M. S. Cabral, E. D. Zanjani, and G. Almeida-Porada, “Generation of functional natural killer and dendritic cells in a human stromal-based serum-free culture system designed for cord blood expansion,” Experimental Hematology, vol. 36, no. 1, pp. 61–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Aranami, S. Miyake, and T. Yamamura, “Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis,” Journal of Immunology, vol. 177, no. 8, pp. 5659–5667, 2006. View at Google Scholar · View at Scopus
  33. B. M. Burt, G. Plitas, J. A. Stableford et al., “CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis,” Journal of Leukocyte Biology, vol. 84, no. 4, pp. 1039–1046, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Tsuda, W. Li, H. Yamanishi et al., “Involvement of CD56bright CD11c+ cells in IL-18-mediated expansion of human γδ T cells,” Journal of Immunology, vol. 186, no. 4, pp. 2003–2012, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Gruenbacher, H. Gander, A. Rahm, W. Nussbaumer, N. Romani, and M. Thurnher, “CD56+ human blood dendritic cells effectively promote TH1-type γδ T-cell responses,” Blood, vol. 114, no. 20, pp. 4422–4431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Papewalis, B. Jacobs, M. Wuttke et al., “IFN-α skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo,” Journal of Immunology, vol. 180, no. 3, pp. 1462–1470, 2008. View at Google Scholar · View at Scopus
  37. D. Homann, A. Jahreis, T. Wolfe et al., “CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells,” Immunity, vol. 16, no. 3, pp. 403–415, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Agematsu, S. Hokibara, H. Nagumo, and A. Komiyama, “CD27: a memory B-cell marker,” Immunology Today, vol. 21, no. 5, pp. 204–206, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Hayakawa and M. J. Smyth, “CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity,” Journal of Immunology, vol. 176, no. 3, pp. 1517–1524, 2006. View at Google Scholar · View at Scopus
  40. A. Silva, D. M. Andrews, A. G. Brooks, M. J. Smyth, and Y. Hayakawa, “Application of CD27 as a marker for distinguishing human NK cell subsets,” International Immunology, vol. 20, no. 4, pp. 625–630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Ganguly, S. Haak, V. Sisirak, and B. Reizis, “The role of dendritic cells in autoimmunity,” Nature Reviews Immunology, vol. 13, no. 8, pp. 566–577, 2013. View at Google Scholar
  42. U. Schleicher, A. Hesse, and C. Bogdan, “Minute numbers of contaminant CD8+ T cells or CD11b+CD11c+ NK cells are the source of IFN-γ in IL-12/IL-18-stimulated mouse macrophage populations,” Blood, vol. 105, no. 3, pp. 1319–1328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S.-R. Chang, K.-J. Wang, Y.-F. Lu et al., “Characterization of early gamma interferon (IFN-γ) expression during murine listeriosis: identification of NK1.1+ CD11c+ cells as the primary IFN-γ-expressing cells,” Infection and Immunity, vol. 75, no. 3, pp. 1167–1176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. I. Caminschi, F. Ahmet, K. Heger et al., “Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells,” Journal of Experimental Medicine, vol. 204, no. 11, pp. 2579–2590, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. H. Fischer, K. A. Jacobson, J. Rose, and R. Zeller, “Fixation and permeabilization of cells and tissues,” CSH Protocols, vol. 2008, Article ID pdb.top36, 2008. View at Google Scholar
  46. M. C. Jacob, M. Favre, and J.-C. Bensa, “Membrane cell permeabilisation with saponin and multiparametric analysis by flow cytometry,” Cytometry, vol. 12, no. 6, pp. 550–558, 1991. View at Google Scholar · View at Scopus
  47. J. Saklatvala, J. Dean, and A. Clark, “Control of the expression of inflammatory response genes,” Biochemical Society Symposium, vol. 70, pp. 95–106, 2003. View at Google Scholar · View at Scopus
  48. J. M. Salvador, P. R. Mittelstadt, G. I. Belova, A. J. Fornace Jr., and J. D. Ashwell, “The autoimmune suppressor Gadd45α inhibits the T cell alternative p38 activation pathway,” Nature Immunology, vol. 6, no. 4, pp. 396–402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. J. L. Dean, M. Brook, A. R. Clark, and J. Saklatvala, “p38 Mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes,” Journal of Biological Chemistry, vol. 274, no. 1, pp. 264–269, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. A. D. Foey, S. L. Parry, L. M. Williams, M. Feldmann, B. M. Foxwell, and F. M. Brennan, “Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: role of the p38 and p42/44 mitogen-activated protein kinases,” Journal of Immunology, vol. 160, no. 2, pp. 920–928, 1998. View at Google Scholar · View at Scopus
  51. M. J. Powell, S. A. Thompson, Y. Tone, H. Waldmann, and M. Tone, “Posttranscriptional regulation of IL-10 gene expression through sequences in the 3′-untranslated region,” Journal of Immunology, vol. 165, no. 1, pp. 292–296, 2000. View at Google Scholar · View at Scopus
  52. O. Ananieva, J. Darragh, C. Johansen et al., “The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling,” Nature Immunology, vol. 9, no. 9, pp. 1028–1036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Maroof, L. Beattie, S. Zubairi, M. Svensson, S. Stager, and P. M. Kaye, “Posttranscriptional regulation of Il10 gene expression allows natural killer cells to express immunoregulatory function,” Immunity, vol. 29, no. 2, pp. 295–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. L. R. Grant, Z.-J. Yao, C. M. Hedrich et al., “Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells,” Genes and Immunity, vol. 9, no. 4, pp. 316–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Perona-Wright, K. Mohrs, F. M. Szaba et al., “Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells,” Cell Host and Microbe, vol. 6, no. 6, pp. 503–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. M. A. Cooper, T. A. Fehniger, A. Fuchs, M. Colonna, and M. A. Caligiuri, “NK cell and DC interactions,” Trends in Immunology, vol. 25, no. 1, pp. 47–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Walzer, M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier, “Natural-killer cells and dendritic cells: ‘l'union fait la force’,” Blood, vol. 106, no. 7, pp. 2252–2258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Ing and M. M. Stevenson, “Dendritic cell and NK cell reciprocal cross talk promotes gamma interferon-dependent immunity to blood-stage Plasmodium chabaudi AS infection in mice,” Infection and Immunity, vol. 77, no. 2, pp. 770–782, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Morandi, L. Mortara, L. Chiossone et al., “Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response,” PLoS ONE, vol. 7, no. 6, Article ID e39170, 2012. View at Google Scholar
  60. A. Sharma, M. Kumar, J. Aich et al., “Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5761–5766, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Flodstrom-Tullberg, Y. T. Bryceson, F. D. Shi, P. Hoglund, and H. G. Ljunggren, “Natural killer cells in human autoimmunity,” Current Opinion in Immunology, vol. 21, no. 6, pp. 634–640, 2009. View at Google Scholar
  62. J. Hanna, T. Gonen-Gross, J. Fitchett et al., “Novel APC-like properties of human NK cells directly regulate T cell activation,” Journal of Clinical Investigation, vol. 114, no. 11, pp. 1612–1623, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. C. W. Chan, E. Crafton, H.-N. Fan et al., “Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity,” Nature Medicine, vol. 12, no. 2, pp. 207–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Taieb, N. Chaput, C. Ménard et al., “A novel dendritic cell subset involved in tumor immunosurveillance,” Nature Medicine, vol. 12, no. 2, pp. 214–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. A. L. Blasius, W. Barchet, M. Cella, and M. Colonna, “Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells,” Journal of Experimental Medicine, vol. 204, no. 11, pp. 2561–2568, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. C. A. Vosshenrich, S. Lesjean-Pottier, M. Hasan et al., “CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells,” Journal of Experimental Medicine, vol. 204, no. 11, pp. 2569–2578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Coulombel and A. Bensussan, “IKDC: a new suit for active NK cells,” Medecine Sciences, vol. 24, no. 5, pp. 521–524, 2008. View at Google Scholar · View at Scopus
  68. S. X. Lu, O. Alpdogan, J. Lin et al., “STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease,” Blood, vol. 112, no. 13, pp. 5254–5258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Franceschini, M. Paroli, V. Francavilla et al., “PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV,” Journal of Clinical Investigation, vol. 119, no. 3, pp. 551–564, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. O. Ahn, B. R. Blazar, J. S. Miller, and M. R. Verneris, “Lineage relationships of human interleukin-22-producing CD56+ RORgammat+ innate lymphoid cells and conventional natural killer cells,” Blood, vol. 121, no. 12, pp. 2234–2243, 2013. View at Google Scholar
  71. A. Laroni, R. Gandhi, V. Beynon, and H. L. Weiner, “IL-27 imparts immunoregulatory function to human NK cell subsets,” PLoS ONE, vol. 6, no. 10, Article ID e26173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Mavropoulos, T. Orfanidou, C. Liaskos et al., “p38 MAPK signaling in pemphigus: implications for skin autoimmunity,” Autoimmune Diseases, vol. 2013, Article ID 728529, 11 pages, 2013. View at Publisher · View at Google Scholar